| Story Views | |
| Now: | |
| Last Hour: | |
| Last 24 Hours: | |
| Total: | |
How an army of pharma lobbyists in Washington have locked in one of the biggest corporate rip-off schemes in America
Tuesday, February 23, 2016 22:15
% of readers think this story is Fact. Add your two cents.
After an 18-month investigation into the high cost of Gilead’s hepatitis C drug Sovaldi—initially listed at $84,000 for a course of treatment or $1,000 per pill—the Senate Finance Committee said the prices did not reflect the cost of research and development and that Gilead cared about “revenue” not “affordability and accessibility.” That sounds like an understatement. Sovaldi and the related pill Harvoni cost Medicare and Medicaid more than $5 billion in 2014, charged senators. Continue reading → Bev Conover Editor & Publisher Intrepid Report https://www.intrepidreport.com https://www.facebook.com/intrepidreport http://twitter.com/#!/Intrepid_Report [email protected]
Source: http://www.intrepidreport.com/archives/17450
